Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
rosacea eczema alopecia ceramide keratosis pityriasis basal cell melanoma keratosis purpuraYour Article Summary
See Latest ArticlesUse of liposomes as drug delivery vehicles for treatment of melanoma
Pigment Cell & Melanoma Research, 06/24/09
Robertson GP et al. - Liposomes delivering chemotherapies, siRNA, asODNs, DNA, and radioactive particles are just some of the promising new nanotechnology based therapies under development for the treatment of melanoma that are discussed in this review.
G. P. Robertson, 06/24/09
| This article is useful to persons developing new therapies to treat patients suffering from malignant melanoma. Nanotechnology, and in particular liposomes, has potential to load multiple targeted therapies, which is believed to be needed for the successful management of this disease. These concepts are reviewed in this article. |
Related Articles
Loss of SNF5 expression correlates with poor patient survival in melanoma
Clinical Cancer Research, 10/12/09
Relevance Score: 97%
Slow-growing melanoma: a dermoscopy follow-up study
British Journal of Dermatology, 10/05/09
Relevance Score: 93%
Dormancy of metastatic melanoma
Pigment Cell & Melanoma Research, 11/11/09
Relevance Score: 91%
ADAM10 Is Upregulated in Melanoma Metastasis Compared with Primary Melanoma
Journal of Investigative Dermatology, 11/03/09
Relevance Score: 91%
KIT as a Therapeutic Target in Melanoma
Journal of Investigative Dermatology, 10/23/09
Relevance Score: 90%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Disseminated Herpes Zoster Mimicking Rheumatoid Vasculitis in a Rheumatoid Arthritis Patient on Etanercept
Dermatology, 12/08/09
Late-Onset Immune-Mediated Adverse Effects after Poly-L-Lactic Acid Injection in Non-HIV Patients: Clinical Findings and Long-Term Follow-Up
Dermatology, 12/08/09
Intravascular Large B-Cell Lymphoma of the Skin: Typical Clinical Manifestations and a Favourable Response to Rituximab-Containing Therapy
Dermatology, 12/08/09
Today in Dermatologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
GLI1 genotypes do not predict basal cell carcinoma risk: a case control study
Molecular Cancer, 12/08/09
Multimodality management for 145 cases of Merkel cell carcinoma
Medical Oncology, 12/08/09
Creation and test of a questionnaire for self-assessment of melanoma risk factors
European Journal of Cancer Prevention, 12/08/09
Sponsor
Article Search
Sponsor